Germline or somatic mutations, chromosomal rearrangements, gene amplification, transcriptional upregulation in MET or alterations in autocrine or paracrine c-MET signalling have been associated with cancer cell proliferation and survival, including in renal cell carcinoma, and linked to disease progression (14). Here, MET is linked to cancer.